Clinical Features of Youth Depression with Attenuated Symptoms of the Schizophrenic Spectrum
https://doi.org/10.30629/2618-6667-2021-19-1-16-25
Abstract
Objective: establishment of clinical and psychometric features of youth depression with attenuated symptoms of the schizophrenic spectrum (ASSS) for early differential diagnosis and nosological assessment.
Patients and methods: clinical and psychometric examination of young 219 inpatients (average age 19.6 ± 2.4 years), first admitted to the clinic “Mental Health Research Centre” from 2011 to 2020 with the first depressive episode with ASSS. Control group of inpatients (52 patients) with “classical” youth depressions without ASSS (average age 19.6 ± 2.4 years). Diagnosis according ICD-10: F32.1, F32.2, F32.28, F32.8.
Results: the psychopathological structure of youth depression with ASSS is characterized by the following types: (1) depression with attenuated psychotic symptoms (APS), which were divided into the subtype (1a) depression with APS and (1b) depression with brief limited intermittent psychotic symptoms (BLIPS); (2) depression with attenuated negative symptoms (ANS), comprising two subtypes (2a) with most emotional damage and (2b) with volitional impairment, and type (3) with attenuated symptoms of disorganization (ASD) in the structure of depressive episode. Clinical and reliable psychometric differences have been established between depressions with ASSS and «classical» youth depressions without ASSS.
Conclusions: youth depression with ASSS is definitely different from “classical” youth depression without ASSS. Differences have been found in the psychopathological structure of youth depression with ASSS, resulting in a typological differentiation.
About the Author
M. A. Omelchenko
FSBSI “Mental Health Research Centre”
Russian Federation
Russian Federation
MD, PhD, Cand. of Sci. (Med.)
Moscow
References
1. Rotshtein VG. Schizophrenia: age at disease onset. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2014;12:23–30. (In Russ.). DOI: 10.17116/jnevro201411412123-30
2. Miettunen J, Immonen J, McGrath J., Isohanni M, Jaaskelainen E. The age of onset of schizophrenia spectrum disorders. In: Girolamo G, McGorry P, Sartorius N. Age of Onset of Mental Disorders. Springer. 2019:55–74. DOI: 10.1093/schbul/sby017.659
3. Woodberry K, Shapiro D, Bryant C, Seidman L. Progress and future directions in research on the psychosis prodrome: A review for clinicians. Harv. Rev. Psychiatry. 2016;24(2):87–103. DOI: 10.1097/HRP.0000000000000109
4. Mazaeva NA. The precursors of schizophrenia: a view on the problem. Psihiatriya i psihofarmakoterapiya imeni P.B. Gannushkina. 2020;3:4–16. (In Russ.).
5. Kekelidze ZI, Bukreeva ND, Demcheva NK, Makushkin EV. Epidemiological indicators of mental disorders in the Russian Federation in 2009–2018. Measures to improve mental health care. Psikhicheskoe zdorovie [Mental Health]. 2019;(10):3–10. (In Russ.). DOI: 10.25557/2074-014X.2019.10.3-10
6. Albert N, Madsen T, Nordentoft M. Early Intervention Service for Young People With Psychosis: Saving Young Lives. JAMA Psychiatry. 2018;75(5):427–428. DOI: 10.1001/jamapsychiatry.2018.0662
7. Andreasen NC, Arndt S, Alliger R, Miller D, Flaum M. Symptoms of schizophrenia. Methods, meanings, and mechanisms. Arch. Gen. Psychiatry. 1995;52:341–351. DOI: 10.1001/archpsyc.1995.03950170015003
8. Liddle PF. Schizophrenic syndromes, cognitive performance and neurological dysfunction. Psychol. Med. 1987;17:49–57. DOI: 10.1017/S0033291700012976
9. Newton R, Rouleau A, Nylander AG, Jean-Yves Loze, Resemann HK, Steeves S, Crespo-Facorro B. Diverse definitions of the early course of schizophrenia — a targeted literature review. NPJ Schizophr. 2018;4(1):21. DOI: 10.1038/s41537-018-0063-7
10. Patel KR, Cherian J, Gohil K, Atkinson D. Schizophrenia: overview and treatment options. PT. 2014;39(9):638–645. PMID: 25210417; PMCID: PMC4159061
11. Fusar-Poli P, Cappucciati M, De Micheli A, Rutigliano G, Bonoldi I, Tognin S, Ramella-Cravaro V, Castagnini A, McGuire P. Diagnostic and prognostic significance of brief limited intermittent psychotic symptoms (BLIPS) in individuals at ultra high risk. Schizophr. Bull. 2017;43:48–56. DOI: 10.1093/schbul/sbw151
12. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition. Arlington, VA, American Psychiatric Association, 2013.
13. Smulevich AB, Dubnitskaya EB, Lobanova VM, Voronova EI, Zhylin VO, Kolyutskaya EV, Samoilova ED, Sorokina Yu. Personality disorders and schizophrenic defect (problem of comorbidity). Zhurnal nevrologii i psihiatrii imeni S.S. Korsakova. 2018;118(11):4–14. (In Russ.). DOI: 10.17116/jnevro20181181114
14. Barkhatova AN. Prognostic importance of the psychopathological remission structure at the initial stage of schizophrenia. S.S. Korsakov Journal of Neurology and Psychiatry/Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2019;119(3):5–11. (In Russ.). DOI: 10.17116/jnevro20191190315
15. Cornblatt B, Lencz T, Obuchowski M. The schizophrenia prodrome: treatment and high-risk perspectives. Schizophr. Res. 2002;54(1–2):177–186. DOI: 10.1016/s0920-9964(01)00365-6
16. Carrión RE, Demmin D, Auther AM, McLaughlin D, Olsen R, Lencz T, Correll CU, Cornblatt BA. Duration of attenuated positive and negative symptoms in individuals at clinical high risk: Associations with risk of conversion to psychosis and functional outcome. J. Psychiatr. Res. 2016;81:95–101 DOI: 10.1016/j.jpsychires.2016.06.021
17. Ilyichev AB, Pozdnyak VV, Vaknin EE, Shishkov VV, Khutyoryanskaya YuV, Grechaniy SV. Psychopathological aspects of early diagnosis of schisotypic disorder: analysis of de-automatization. Psihiatriya i psihofarmakoterapiya imeni P.B. Gannushkina. 2020;3:17–20. (In Russ.).
18. Rumyantsev AO, Omel’chenko MA, Kaleda VG. Attenuated psychotic symptoms in the structure of youth depression (clinical and psychopathological aspects). Russian journal of psychiatry. 2018;1:61–70. (In Russ.). eLIBRARY ID: 32636653
19. Strauss G, Horan W, Kirkpatrick B, Fischer B, Keller W, Miski P. Deconstructing negative symptoms of schizophrenia: avolition- apathy and diminished expression clusters predict clinical presentation and functional outcome. J. Psychiatr. Res. 2013;47(6):783–790. DOI: 10.1016/j.jpsychires.2013.01.015
20. Oleichik IV. Psychopathology, typology and nosological evaluation of juvenile endogeneous depressions: a clinical and follow-up study. Zhurnal nevrologii i psihiatrii imeni S.S. Korsakova. 2011;111(2):10–18. (In Russ.). eLIBRARY ID: 16597152
21. Marder SR, Galderisi S. The current conceptualization of negative symptoms in schizophrenia. World Psychiatry. 2017;16(1):14–24. DOI: 10.1002/wps.20385
22. Correll CU, Schooler NR. Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment. Neuropsychiatr Dis. Treat. 2020;16:519–534. DOI: 10.2147/NDT.S225643
Review
For citations:
Omelchenko M.A. Clinical Features of Youth Depression with Attenuated Symptoms of the Schizophrenic Spectrum. Psychiatry (Moscow) (Psikhiatriya). 2021;19(1):16-25. (In Russ.) https://doi.org/10.30629/2618-6667-2021-19-1-16-25
Views:
557
Email this article 
